title: Statistical evaluation of drug efficacy for bridging study in companion diagnostic test trials.
abstract: Personalized medicine is an area of growing attention in medical research and practice. A market-ready companion diagnostic test (CDx) is used in personalized medicine for identifying the best treatment for an individual patient. Unfortunately, development of CDx may lag behind the development of the drug, and consequently we use a clinical trial assay (CTA) to enroll patients into the drug pivotal clinical trial instead. Thus, when CDx becomes available, a bridging study will be required to assess the drug efficacy in the CDx intended use (CDx IU) population. Due to missingness of the CDx results that could be associated with randomization, one challenge we face in a bridging study is covariate imbalance between treatment arms for the subpopulation with both positive CDx and CTA. In this paper, we evaluate the performance of two methods in bridging studies under a causal inference framework. Particularly, we aim to use the propensity score method with doubly robust estimation and optimal matching to address the challenge. We extend under a current framework on drug efficacy estimation in the CDx IU population, using data from both the bridging study and the CTA drug pivotal clinical trial. Both approaches are discussed in the context of a randomized bridging study, and a targeted design clinical trial with simulations, followed by analyzing simulated data that mimic a real ongoing clinic trial.
authors.affiliation: a Department of Biostatistics , University of Washington , Seattle , Washington , USA.
authors.forename: Yunqi
authors.initials: Y
authors.lastname: Bu
authors.affiliation: a Department of Biostatistics , University of Washington , Seattle , Washington , USA.|b Biostatistics Unit, Seattle-Denver HSR&D Center of Innovation , VA Puget Sound Health Care System , Seattle , Washington , USA.
authors.forename: Xiao-Hua
authors.initials: XH
authors.lastname: Zhou
mesh_terms: D002986:Clinical Trials as Topic; D019937:Diagnostic Techniques and Procedures / Q000706:statistics & numerical data*; D004341:Drug Evaluation / Q000706:statistics & numerical data*; D006801:Humans; D057285:Precision Medicine; D057216:Propensity Score; D016032:Randomized Controlled Trials as Topic; D012107:Research Design
keywords: Bridging study; causal inference; clinical trial assay; companion diagnostic assay; covariate imbalance; device-drug pivotal clinical trial; doubly robust estimator; drug efficacy; optimal matching; personalized medicine